| Structure |
Chemical Name |
CAS |
MF |
 |
N-Desmethylondansetron |
99614-14-9 |
C17H17N3O |
 |
CHEMPACIFIC 59929 |
856240-62-5 |
C18H24O4 |
 |
Linagliptin ImpurityABCDEF |
|
|
|
|
Bimatoprost Impurity 17 |
|
|
|
|
Bumetanide Impurity 10 |
|
|
|
|
Cefoxitin EP Impurity E (R-methoxy cefoxitin) |
|
|
 |
4(1H)-Pyrimidinone, 5-amino-6-chloro-2-(propylthio)- |
2512210-21-6 |
C7H10ClN3OS |
![Carbamic acid, N-[(1S)-1-methyl-2-oxo-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester](/CAS/20210305/GIF/2151127-61-4.gif) |
Carbamic acid, N-[(1S)-1-methyl-2-oxo-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester |
2151127-61-4 |
C24H23NO4 |
 |
1-(Chlormethyl)-4-(dichlormethyl)benzol |
7398-44-9 |
C8H7Cl3 |
 |
4,4'-(Propan-1,3-diyl)bismorpholin |
48152-09-6 |
C11H22N2O2 |
 |
1-benzyl-4-phenylpiperidin-4-ol |
63843-83-4 |
C18H21NO |
![[(±)-(4-Amino-2-hydroxy-4-oxobutyl)trimethylammonium]chlorid](/CAS/GIF/5261-99-4.gif) |
[(±)-(4-Amino-2-hydroxy-4-oxobutyl)trimethylammonium]chlorid |
5261-99-4 |
C7H18ClN2O2+ |
 |
17,21-Dihydroxy-16β-methylpregna-1,4,9(11)-trien-3,20-dion |
13504-15-9 |
C22H28O4 |
![Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-phenyl-4-pyrimidinyl]-N'-propyl-](/CAS/20210305/GIF/2300968-87-8.gif) |
Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-phenyl-4-pyrimidinyl]-N'-propyl- |
2300968-87-8 |
C19H21BrN6O4S |
 |
Benzeneacetonitrile, 4-(4-chloro-1-oxobutyl)-α,α-dimethyl- |
169032-17-1 |
C14H16ClNO |
|
|
Oseltamivir Impurity 103 |
|
|
|
|
Oseltamivir Impurity 101 |
|
|
|
|
Oseltamivir Impurity 90 |
|
|
|
|
Oseltamivir Impurity 79 |
|
|
|
|
Oseltamivir Impurity 73 |
|
|
|
|
Oseltamivir Impurity 69 |
|
|
 |
10-Methoxy-6-methylergolin-8β-methanol |
35121-60-9 |
C17H22N2O2 |
 |
Azilsartan medoxomil impurity261 |
2514957-39-0 |
C16H16FN3O4 |
![Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(2-methoxy-2-oxoethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester](/CAS/20210305/GIF/127373-95-9.gif) |
Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(2-methoxy-2-oxoethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester |
127373-95-9 |
C21H24N2O7S |
|
|
Fulvestrant Impurity 1 |
|
|
|
|
CefazolinH020-02-I-02 |
|
|
![(E)-3-[cyano(2,3-dichlorophenyl)methylene]carbazamidine](/CAS/GIF/94213-24-8.gif) |
(E)-3-[cyano(2,3-dichlorophenyl)methylene]carbazamidine |
94213-24-8 |
C9H7Cl2N5 |
![5-Pyrimidinecarboxylic acid, 4-amino-6-[1-[(1R)-2-cyano-1-cyclopentylethyl]-1H-pyrazol-4-yl]-](/CAS/20210305/GIF/2606144-44-7.gif) |
5-Pyrimidinecarboxylic acid, 4-amino-6-[1-[(1R)-2-cyano-1-cyclopentylethyl]-1H-pyrazol-4-yl]- |
2606144-44-7 |
C16H18N6O2 |
![3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-acetyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-](/CAS/20210305/GIF/1395471-26-7.gif) |
3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-acetyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo- |
1395471-26-7 |
C23H26FN3O5 |
![N-[3-Acetyl-4-(oxiranylmethoxy)phenyl]butyramid](/CAS/GIF/28197-66-2.gif) |
N-[3-Acetyl-4-(oxiranylmethoxy)phenyl]butyramid |
28197-66-2 |
C15H19NO4 |
![8-Isopropyl-8-azabicyclo[3.2.1]octan-3-on](/CAS/GIF/3423-28-7.gif) |
8-Isopropyl-8-azabicyclo[3.2.1]octan-3-on |
3423-28-7 |
C10H17NO |
|
|
Sitagliptin EP Impurity 4 |
|
|
![1-[3,5-bis(phenylmethoxy)phenyl]-2-bromoethan-1-one](/CAS/GIF/28924-18-7.gif) |
1-[3,5-bis(phenylmethoxy)phenyl]-2-bromoethan-1-one |
28924-18-7 |
C22H19BrO3 |
![Benzenesulfonic acid, 4-[2-(2-chloro-4-hydroxyphenyl)hydrazinyl]-](/CAS/20210305/GIF/2174956-62-6.gif) |
Benzenesulfonic acid, 4-[2-(2-chloro-4-hydroxyphenyl)hydrazinyl]- |
2174956-62-6 |
C12H11ClN2O4S |
|
|
4,4',6-trioxo-4,4',5,6,7,7'-hexahydro-1H,1'H-[5,6'-bipyrrolo[2,3-d]pyrimidine]-5,5'-diyl)bis(ethane-2,1-diyl))bis(benzoyl))bis(azanediyl))dipentanedioic acid |
|
|
|
|
Cefotiam impurity 07 |
|
|
 |
Benzo-1,3-dioxol-5-olacetat |
326-58-9 |
C9H8O4 |
 |
2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl- 1,3-dioxan-4-yl)acetic acid |
775571-58-9 |
C9H15ClO4 |
 |
Ruxolitinib Impurity 1 |
3027185-21-0 |
C25H29N7 |
|
|
Cefradine Impurity L |
|
|
 |
(8beta)-10methoxy-6-dimethylergoline-8-methanol-5-bromo-3-pyridinecarboxylate(ester) |
35264-46-1 |
C23H24BrN3O3 |
|
|
Cephalexin Open-Ring Impurity |
|
|
|
|
Urapidil Impurity 18 |
|
|
|
|
Flomoxef Impurity IV |
|
|
|
|
Pitavastatin Impurity 54 Complete Set |
|
|
|
|
Cetrorelix Impurity 15 |
|
|
|
|
Brivaracetam Impurity 46 |
|
|
|
|
Peramivir Intermediate Impurity 38 |
|
|
|
|
Peramivir Guanidine Acetyl Positional Heterogeneous Impurities |
|
|
|
|
Ticagrelor impurity P drops |
|
|
|
|
3-[4-(2-isopropoxyethoxymethyl)phenoxy]-2-(isopropylamino)propan-1-ol |
|
|
|
|
Pemetrexed Disodium Impurity 31-40 |
|
|
|
|
Paclitaxel EP impurity drops |
|
|
|
|
Ticagrelor impurity PDD |
|
|
|
|
octahydro-1H,8H-dipyrazolo[1,2-a:1',2'-e][1,2,5,6]tetrazocine |
|
|
|
|
Bimatoprost Impurity S |
|
|
 |
BIS(2,6-DIPHENYLPHENOXY)NIOBIUM(V) CHLOR |
699012-35-6 |
C42H32Cl3NbO2 |
|
|
Brivaracetam Impurity 62 |
|
|
|
|
Lumateperone Impurity 4 |
|
|
|
|
SugammadexImpurity021 |
|
|
|
|
Pabocillin Impurity 28 |
|
|
|
|
Cefmetazole Sodium Impurity C |
|
|
|
|
Ceftriaxone Sodium Oxide Impurity |
|
|
|
|
2-[4-(Azidomethyl)phenyl]benzamide |
|
|
![1H-Benzimidazole-7-carboxylic acid, 1-[[2'-[4,5-dihydro-4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-5-oxo-1,2,4-oxadiazol-3-yl][1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-](/CAS/20210305/GIF/1985638-55-8.gif) |
1H-Benzimidazole-7-carboxylic acid, 1-[[2'-[4,5-dihydro-4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-5-oxo-1,2,4-oxadiazol-3-yl][1,1'-biphenyl]-4-yl]methyl]-2-ethoxy- |
1985638-55-8 |
C30H24N4O8 |
![2H-1,4-Benzoxazin-3(4H)-one, 8-[(1R)-2-bromo-1-hydroxyethyl]-6-(phenylmethoxy)-](/CAS/20210305/GIF/2248125-51-9.gif) |
2H-1,4-Benzoxazin-3(4H)-one, 8-[(1R)-2-bromo-1-hydroxyethyl]-6-(phenylmethoxy)- |
2248125-51-9 |
C17H16BrNO4 |
![Morpholine, 4-[4-(1,1-dimethylethoxy)-1,2,5-thiadiazol-3-yl]-](/CAS/20210305/GIF/158636-99-8.gif) |
Morpholine, 4-[4-(1,1-dimethylethoxy)-1,2,5-thiadiazol-3-yl]- |
158636-99-8 |
C10H17N3O2S |
|
|
Pemetrexed disodium Impurity 30 |
|
|
|
|
(S)-4,6,7,11-tetrahydroxy-9-(2-hydroxyacetyl)-7,8-dihydrotetracene-5,12-dione |
|
|
|
|
Ruxolitinib ImpurityABCDEFGHJKL |
|
|
|
|
Rosuvastatin Impurity 153 |
|
|
|
|
Rosuvastatin Impurity 138 |
|
|
|
|
Rosuvastatin Impurity 127 |
|
|
|
|
Oxacillin sodium EP impurity J |
|
|
|
|
Piperacillin Sodium EP Impurity P |
|
|
|
|
Ertapenem Impurity B(USP) |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2458312-06-4 |
C27H30N2O6 |
 |
15(R)-17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA |
41639-71-8 |
C23H32O5 |
|
|
(5R,6S)-6-((R)-1-hydroxyethyl)-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-en-7-one |
|
|
 |
Acetamide, N-(4-hydroxyphenyl)-N-nitroso- |
146897-60-1 |
C8H8N2O3 |
![3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-](/CAS/20210305/GIF/2402776-83-2.gif) |
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]- |
2402776-83-2 |
C16H17N7O2S |
|
|
Iohexol ImpuritiesE |
|
|
 |
TERT-BUTYL (R)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE |
404958-08-3 |
C10H17ClO4 |
|
|
2-(3-(4-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
|
|
|
|
8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-yl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine |
|
|
|
|
Bumetanide Photodegradable Impurity 16 |
|
|
|
|
Bisoprolol Impurity 47 |
|
|
|
|
Gadobutrol Impurity 11(Ammonium salt) |
|
|
|
|
Flomoxef Impurity F |
|
|
|
|
Tegoprazan Impurity 15 |
|
|
|
|
Nirmatrelvir Impurity 8 |
|
|
|
|
Nirmatrelvir Impurity 2 |
|
|
|
|
(5-(2-fluorophenyl)-1H-pyrrol-3-yl)methanamine hydrochloride |
|
|
|
|
Rocuronium Bromide Impurity 24 、25 |
|
|
|
|
Roxadustat Impurity 17 |
|
|
|
|
Perospirone Impurity 20 |
1002359-81-0 |
|
|
|
Dolutegravir Impurity 19 |
|
|
|
|
Cephalexin Impurity I |
|
|
|
|
Fondaparinux sodium impurity 6 |
|
|
|
|
Fondaparinux sodium impurity 2 |
|
|